AtriCure
ATRC
$23.14
Share price
-0.13%
Change (1 day)
-47.40%
Change (1 year)
Categories
AtriCure (ATRC) - Cash on Hand
Cash on Hand as of December 2023 : $0.13 B
According to AtriCure's latest financial reports the company has $0.13 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
AtriCure - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | 13.35% |
| 2022-12-31 | $0.12 B | 1.7% |
| 2021-12-31 | $0.11 B | -51.24% |
| 2020-12-31 | $0.24 B | 198.55% |
| 2019-12-31 | $81.8 M | -34.24% |
| 2018-12-31 | $0.12 B | 261.1% |
| 2017-12-31 | $34.45 M | -21.72% |
| 2016-12-31 | $44 M | 27.27% |
| 2015-12-31 | $34.57 M | -42.03% |
| 2014-12-31 | $59.64 M | 127.57% |
| 2013-12-31 | $26.21 M | 118.43% |
| 2012-12-31 | $12 M | -15.39% |
| 2011-12-31 | $14.18 M | 12.83% |
| 2010-12-31 | $12.57 M | -20.04% |
| 2009-12-31 | $15.72 M | 37.33% |
| 2008-12-31 | $11.44 M | -42.78% |
| 2007-12-31 | $20 M | 2.66% |
| 2006-12-31 | $19.48 M | -42.35% |
| 2005-12-31 | $33.8 M | 553.16% |
| 2004-12-31 | $5.17 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 16,600.30% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 5,961.11% | 🇮🇪 Ireland |
 Abiomed ABMD | $0.82 B | 497.57% | 🇺🇸 USA |
 Boston Scientific BSX | $0.86 B | 530.08% | 🇺🇸 USA |
 Edwards Lifesciences EW | $1.64 B | 1,097.87% | 🇺🇸 USA |
 Teleflex TFX | $0.22 B | 62.33% | 🇺🇸 USA |
 Cooper Companies COO | $0.13 B | -1.52% | 🇺🇸 USA |